# Gemini Space Station, Inc.: overview

GEMI · Nasdaq · CIK 2055592 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/gemi.md) · [Financials](/companies/gemi/financials.md) · [Filings](/companies/gemi/filings.md) · [Insiders](/companies/gemi/insiders.md)

Latest reported revenue: [$45.5m](/filings/0002055592-26-000065.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 13, 2026 (XBRL us-gaap:Revenues, accession 0002055592-26-000065).

## Last eight quarters

| Line item | Unit | period not labelled (2024-09-30) | period not labelled (2024-12-31) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [24.5](/filings/0002055592-25-000009.md) | [43.3 d](/filings/0002055592-26-000026.md) | [35.3](/filings/0002055592-26-000050.md) | [33.3](/filings/0002055592-26-000065.md) | [50.6](/filings/0002055592-25-000009.md) | [60.3 d](/filings/0002055592-26-000026.md) | [50.3](/filings/0002055592-26-000050.md) | [45.5](/filings/0002055592-26-000065.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [(213.0%)](/filings/0002055592-25-000009.md) | [(66.4%) d](/filings/0002055592-26-000026.md) | [(136.0%)](/filings/0002055592-26-000050.md) | [(196.6%)](/filings/0002055592-26-000065.md) | [(238.6%)](/filings/0002055592-25-000009.md) | [(184.6%) d](/filings/0002055592-26-000026.md) | [(187.4%)](/filings/0002055592-26-000050.md) | [(169.2%)](/filings/0002055592-26-000065.md) |
| Net margin | % | [(367.5%)](/filings/0002055592-25-000009.md) | [(62.3%) d](/filings/0002055592-26-000026.md) | [(422.6%)](/filings/0002055592-26-000050.md) | [(400.2%)](/filings/0002055592-26-000065.md) | [(315.1%)](/filings/0002055592-25-000009.md) | [(233.4%) d](/filings/0002055592-26-000026.md) | [(216.8%)](/filings/0002055592-26-000050.md) | [(236.9%)](/filings/0002055592-26-000065.md) |
| Diluted EPS | $ per share | [(18.33)](/filings/0002055592-25-000009.md) | not reported | [(30.34)](/filings/0002055592-26-000050.md) | [(27.08)](/filings/0002055592-26-000065.md) | [(6.67)](/filings/0002055592-25-000009.md) | not reported | [(0.93)](/filings/0002055592-26-000050.md) | [(0.89)](/filings/0002055592-26-000065.md) |
| Free cash flow | $m | not reported | [(5.4) d](/filings/0002055592-26-000026.md) | [(18.6)](/filings/0002055592-26-000050.md) | [(0.3) d](/filings/0002055592-26-000065.md) | [(62.8) d](/filings/0002055592-25-000009.md) | [(138) d](/filings/0002055592-26-000026.md) | [(54.6)](/filings/0002055592-26-000050.md) | [(51.5) d](/filings/0002055592-26-000065.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure.

## Last five fiscal years

| Line item | Unit | FY (2023-12-31) | FY (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: |
| Revenue | $m | [98.1](/filings/0002055592-26-000026.md) | [142](/filings/0002055592-26-000026.md) | [180](/filings/0002055592-26-000026.md) |
| Gross margin | % | not reported | not reported | not reported |
| Operating margin | % | [(317.5%)](/filings/0002055592-26-000026.md) | [(116.6%)](/filings/0002055592-26-000026.md) | [(192.5%)](/filings/0002055592-26-000026.md) |
| Net margin | % | [(325.7%)](/filings/0002055592-26-000026.md) | [(111.5%)](/filings/0002055592-26-000026.md) | [(324.6%)](/filings/0002055592-26-000026.md) |
| Diluted EPS | $ per share | [(66.25)](/filings/0002055592-26-000026.md) | [(32.24)](/filings/0002055592-26-000026.md) | [(15.52)](/filings/0002055592-26-000026.md) |
| Free cash flow | $m | [(208)](/filings/0002055592-26-000026.md) | [(110)](/filings/0002055592-26-000026.md) | [(220)](/filings/0002055592-26-000026.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/gemi/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [ParaFi Capital LP](/funds/1919332.md) | 2026-06-30 | $14.6m | 3,428,888 |  | Added +2,782,786 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $12.4m | 1,200,409 |  | Added +728,057 |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $12.1m | 2,845,263 |  | Added +2,355,814 |
| [MARSHALL WACE, LLP](/funds/1318757.md) | 2026-06-30 | $6.1m | 1,436,034 |  | Added +1,050,324 |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $5.4m | 1,277,798 |  | Added +97,557 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $5.4m | 1,270,274 |  | Added +628,030 |
| [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $3.0m | 714,400 | Call | Reduced −227,600 |
| [Commonwealth Bank of Australia](/funds/8565.md) | 2026-06-30 | $3.0m | 714,284 |  | Unchanged |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $2.8m | 662,097 |  | Added +591,897 |
| [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $2.4m | 565,404 |  | Added +130,618 |

## Recent filings

[All 106 filings](/companies/gemi/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-14 | 13:16 ET | [8-K](/filings/0001104659-26-115771.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-115771 |
| 2026-08-13 | 20:43 ET | [10-Q](/filings/0002055592-26-000065.md) | Quarterly report, period 2026-06-30 | 0002055592-26-000065 |
| 2026-08-13 | 20:31 ET | [8-K](/filings/0002055592-26-000063.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0002055592-26-000063 |
| 2026-06-15 | 21:05 ET | [8-K](/filings/0002055592-26-000055.md) | 5.07 Shareholder vote results | 0002055592-26-000055 |
| 2026-05-18 | 21:02 ET | [SCHEDULE 13D](/filings/0001193125-26-229103.md) | Ownership report, active investor | 0001193125-26-229103 |
| 2026-05-15 | 22:03 ET | [10-Q](/filings/0002055592-26-000050.md) | Quarterly report, period 2026-03-31 | 0002055592-26-000050 |
| 2026-05-14 | 20:34 ET | [8-K](/filings/0002055592-26-000048.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0002055592-26-000048 |
| 2026-04-30 | 20:22 ET | [DEF 14A](/filings/0002055592-26-000040.md) | Proxy statement, period 2026-06-15 | 0002055592-26-000040 |
| 2026-03-31 | 20:54 ET | [10-K](/filings/0002055592-26-000026.md) | Annual report, period 2025-12-31 | 0002055592-26-000026 |
| 2026-03-19 | 20:08 ET | [8-K](/filings/0002055592-26-000023.md) | 2.02 Results of operations | 0002055592-26-000023 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0002055592-26-000026.md), filed Mar 31, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/476e11b8-e108-425e-b17b-eef9b85c8d0c)

## About the filer

- CIK: 2055592
- Tickers: GEMI
- Exchange: Nasdaq
- SIC code: 6199 Finance Services
- State of incorporation: NV
- Filer category: <br>Emerging growth company

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.